Heinrich Dreismann
CIK: 0001379372
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (25.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 4, 2026MYGN
MYRIAD GENETICS INC
Award(A)Direct59.7K shares- - Feb 13, 2026MYNZ
MAINZ BIOMED N.V.
Award(A)Direct45K shares- - Jun 5, 2025MYGN
MYRIAD GENETICS INC
Award(A)Direct49.8K shares- - Sep 9, 2024MYGN
MYRIAD GENETICS INC
Sale(S)Direct10K shares at avg. $27.05$271K
1-4 of 4 transactions
About Dreismann Heinrich
Dreismann Heinrich (SEC CIK 0001379372) files insider reports with the SEC as Director of MYRIAD GENETICS INC (MYGN) and Director of MAINZ BIOMED N.V. (MYNZ).
Signal8 holds 5 ownership filings by Dreismann Heinrich (1 Form 3, 4 Form 4), filed between Sep 9, 2024 and Jun 5, 2026. Those filings report 4 transactions, from Sep 9, 2024 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Dreismann Heinrich's filings is in SALT LAKE CITY, UT.
Recent filings by Dreismann Heinrich
Other insiders filing for MYRIAD GENETICS INC (MYGN)
- Fox Jennifer Lynne, Chief Legal & Corp Strategy
- Wheeler Benjamin Richard, Chief Financial Officer
- Donnelly Brian J, Chief Commercial Officer
- Sikri Vishal, EVP, Commercial
- Skovronsky Daniel, Director
- Raha Samraat S., President and CEO